Cargando…
Effects of Rivaroxaban on Platelet Activation and Platelet–Coagulation Pathway Interaction: In Vitro and In Vivo Studies
INTRODUCTION: Activation of coagulation and platelets is closely linked, and arterial thrombosis involves coagulation activation as well as platelet activation and aggregation. In these studies, we investigated the possible synergistic effects of rivaroxaban in combination with antiplatelet agents o...
Autores principales: | Perzborn, Elisabeth, Heitmeier, Stefan, Laux, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598653/ https://www.ncbi.nlm.nih.gov/pubmed/25848131 http://dx.doi.org/10.1177/1074248415578172 |
Ejemplares similares
-
Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
por: Perzborn, E, et al.
Publicado: (2014) -
The discovery of rivaroxaban: translating preclinical assessments into clinical practice
por: Kubitza, Dagmar, et al.
Publicado: (2013) -
Platelets and coagulation in infection
por: Davis, Rachelle P, et al.
Publicado: (2016) -
NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis
por: Vara, Dina, et al.
Publicado: (2020) -
Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation
por: Brouns, Sanne L. N., et al.
Publicado: (2020)